Status:
COMPLETED
Prognosis of Signet Ring Cells in Upper Digestive Neoplasms
Lead Sponsor:
University Hospital, Lille
Conditions:
Signet Ring Cell Carcinoma
Stomach Disease
Eligibility:
All Genders
18-95 years
Brief Summary
Background • A major increase in incidence of signet ring cell adenocarcinomas (ADCI) of the upper digestive tract in western countries * Discordant results in the literature concerning the prognosis...
Detailed Description
stomach cancer signet ring cell carcinoma prognosis chemotherapy
Eligibility Criteria
Inclusion
- All consecutive patients taken care of, for a proven histologically adenocarcinoma (ADCI and ADNCI) of the esophagus, the esogastric junction, or the stomach, in surgical or medical oncology investigator centers, will be saved in a given database.
- For whom the first consultation took place between January 1997 and January 2010
- As they benefit from a medical and/or surgical support (primitive cancer being or not resected), whatever the metastatic or the recurrence situation was.
Exclusion
- Histological type other than adenocarcinoma
- Other localization than esogastric junction, esophagus or stomach
Key Trial Info
Start Date :
March 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT01249859
Start Date
March 1 2010
End Date
December 1 2010
Last Update
December 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Lille
Lille, France, 59037